The 8th Annual Les Turner Symposium brought together investigators, clinicians, patients and families to share the latest discoveries in ALS research, promote scientific collaboration and provide patient education.
Yearly Archives: 2018
The more sensitive a person is to the bitter taste of caffeine, the more coffee they tend to drink, according to a new study.
Dimitri Krainc, MD, received the Soriano Award at the American Neurological Association (ANA) 143rd Annual Meeting.
A recent lecture by Quinn Capers IV, MD, associate dean for admissions at the Ohio State University College of Medicine, discussed how to reduce implicit race and gender bias in healthcare and medical school admissions.
The Simpson Querrey Center for Epigenetics is connecting the Northwestern academic and medical community to integrate the study of epigenetics into science and clinical care.
Alex Ayala, a second-year medical student also pursuing a master’s degree in public health, is the president of Chicago Medicine Street Outreach, a student organization that provides care and support to the homeless.
A Northwestern University experimental therapeutic targeting a specific protein kinase reversed neurological symptoms in a mouse genetic model of autism, according to a recent Northwestern Medicine study.
Scientists have identified a novel regulator of liver metabolism, which could serve as a potential therapeutic target for obesity, type 2 diabetes and related conditions.
Northwestern Medicine scientists have demonstrated that mitochondrial damage plays a critical early role in a group of diseases, including forms of ALS and dementia.
A new wireless, Band-Aid-like sensor developed at Northwestern University could revolutionize the way patients manage hydrocephalus — a potentially life-threatening condition in which excess fluid builds up in the brain.